Qatar cuts key interest rates by 25 bps    Global pressure mounts on Israel as Gaza death toll surges, war deepens    Egypt targets 7.7% AI contribution to GDP by 2030: Communications Minister    Irrigation Minister highlights Egypt's water challenges, innovation efforts at DAAD centenary celebration    Egypt discusses strengthening agricultural ties, investment opportunities with Indian delegation    Al-Sisi welcomes Spain's monarch in historic first visit, with Gaza, regional peace in focus    Cairo governor briefs PM on Khan el-Khalili, Rameses Square development    El Gouna Film Festival's 8th edition to coincide with UN's 80th anniversary    Egypt expands medical, humanitarian support for Gaza patients    Egypt condemns Israeli offensive in Gaza City, warns of grave regional consequences    Cairo University, Roche Diagnostics inaugurate automated lab at Qasr El-Ainy    Egypt investigates disappearance of ancient bracelet from Egyptian Museum in Tahrir    Egypt launches international architecture academy with UNESCO, European partners    Egypt signs MoUs with 3 European universities to advance architecture, urban studies    Egypt's Sisi, Qatar's Emir condemn Israeli strikes, call for Gaza ceasefire    Egypt condemns terrorist attack in northwest Pakistan    Egyptian pound ends week lower against US dollar – CBE    Egypt hosts G20 meeting for 1st time outside member states    Egypt to tighten waste rules, cut rice straw fees to curb pollution    Egypt seeks Indian expertise to boost pharmaceutical industry    Egypt prepares unified stance ahead of COP30 in Brazil    Egypt harvests 315,000 cubic metres of rainwater in Sinai as part of flash flood protection measures    Al-Sisi says any party thinking Egypt will neglect water rights is 'completely mistaken'    Egyptian, Ugandan Presidents open business forum to boost trade    Egypt's Sisi, Uganda's Museveni discuss boosting ties    Egypt's Sisi warns against unilateral Nile measures, reaffirms Egypt's water security stance    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Marijuana may ease multiple sclerosis symptoms
New clinical trials suggest that marijuana smoking could alleviate muscle cramps associated with MS; Researchers are unclear whether downsides of smoking are worth it
Published in Ahram Online on 15 - 05 - 2012

People with multiple sclerosis have long said that smoking marijuana helps ease their painful muscle cramping. And a new clinical trial suggests they are not just blowing smoke.
The study, published Monday, found that for 30 MS patients with muscle "spasticity," a few days of marijuana smoking brought some relief.
But the big caveat, researchers say, is that it's not clear that the downsides of pot smoking are worth it.
Some people with MS are already using medical marijuana to treat certain symptoms, including spasticity -- when the muscles in the legs or arms contract painfully, in something akin to a "charley horse."
There is some science behind the idea: The body naturally produces cannabinoids, the group of chemicals found in marijuana. And studies have suggested the cannabinoid receptors on our cells help regulate muscle spasticity.
But the evidence that pot smoking actually helps with spasticity has been anecdotal.
"We've heard from patients that marijuana helps their spasticity, but I think a lot us thought, ‘Well, it's probably just making you feel good,'" said Dr. Jody Corey-Bloom, the lead researcher on the new study.
"I think this study shows that yes, (marijuana) may help with spasticity, but at a cost," said Corey-Bloom, of the University of California, San Diego.
The cost, her team found, is that smoking caused fatigue and dizziness in some users, and generally slowed down people's mental skills soon after they used marijuana.
But it's not clear if that would have any long-term consequences, Corey-Bloom said.
About 400,000 people in the United States have MS, a chronic disease in which the protective coating around nerve fibers starts breaking down.
The new study, reported in the Canadian Medical Association Journal, included 30 MS patients with muscle spasticity that had failed to get better with standard medication.
Corey-Bloom's team had each patient smoke marijuana or "placebo" joints -- which looked, smelled and tasted like the real thing, but lacked the active ingredient in marijuana, known as THC.
Each patient smoked marijuana once a day for three days and used the placebo cigarette once a day on three separate days. Before and after each treatment, an independent rater assessed the patients' muscle spasticity.
Overall, the study found, measures of spasticity dropped an average of three points --about 30 percent -- on a 24-point scale when patients smoked marijuana, but didn't change after they smoked the placebo.
The issue of treating spasticity is "certainly an important one," said Nicholas LaRocca, vice president of healthcare delivery and policy research at the National MS Society.
"Spasticity is a big problem for many people with MS, and the current medications don't necessarily work for everyone," said LaRocca, who was not involved in the new study.
"But smoking marijuana does not appear to be a long-term solution, because of the cognitive effects," he told Reuters Health.
People with MS are already at some risk of "cognitive changes," LaRocca pointed out, so the potential for lasting effects from long-term marijuana smoking is a concern.
However, LaRocca said, researchers are developing cannabinoid-based medications for MS. That includes a cannabinoid mouth spray called Sativex that has been approved in the UK, Canada, Spain and New Zealand to treat MS-related spasticity.
Research into cannabinoids and spasticity should continue, LaRocca said, because medications may be able to harness the benefits of specific cannabis compounds, without the side effects linked to smoking pot.
Both LaRocca and Corey-Bloom said there were limitations to the current study.
"Blinding" people as to whether they are on marijuana or a placebo is tough since the drug creates a "high" feeling.
In this study, 17 of 30 patients were able to correctly guess whether they were using marijuana or a placebo at each of their six visits with the researchers. And the rest often guessed correctly.
"It's pretty clear that the patients were not really blinded," LaRocca said. "What effects that might have had on the results is unclear."
Corey-Bloom said that should not have influenced the spasticity findings, since an independent researcher (who didn't know whether patients were smoking marijuana or the placebo) rated spasticity using a standard scale.
But another limitation, she pointed out, is that the study looked at the effects, and side effects, of marijuana over only a few days. "We can't say anything about long-term effects," Corey-Bloom told Reuters Health.
For now, LaRocca recommended that people with spasticity see a doctor experienced in treating MS. And if you're on an anti-spasticity medication and it's not working well enough, or the side effects are too much, tell your doctor, he said.
For some people, a change in the medication dose might help.
http://english.ahram.org.eg/News/41698.aspx


Clic here to read the story from its source.